Privia Health Group (NASDAQ:PRVA) Given New $24.00 Price Target at Barclays

Privia Health Group (NASDAQ:PRVA) had its price objective increased by Barclays from $23.00 to $24.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other equities research analysts also recently weighed in on PRVA. Robert W. Baird lifted their price objective on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. Needham & Company LLC reiterated a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Canaccord Genuity Group boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, JMP Securities reiterated a “market outperform” rating and set a $29.00 target price on shares of Privia Health Group in a research report on Monday, April 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $27.46.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $23.32 on Tuesday. Privia Health Group has a 52-week low of $16.37 and a 52-week high of $26.09. The firm has a market capitalization of $2.84 billion, a PE ratio of 233.22, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. The company’s fifty day moving average price is $23.37 and its two-hundred day moving average price is $22.71.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 15,100 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the completion of the sale, the chief executive officer now owns 454,281 shares in the company, valued at $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. The trade was a 3.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,579 shares of company stock worth $1,226,367. Corporate insiders own 10.70% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. US Bancorp DE lifted its holdings in Privia Health Group by 2.4% in the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after buying an additional 429 shares during the period. Quadrant Capital Group LLC increased its holdings in Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after purchasing an additional 511 shares during the last quarter. Park Avenue Securities LLC boosted its holdings in Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock worth $342,000 after buying an additional 532 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of Privia Health Group by 8.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after buying an additional 533 shares during the period. Finally, CWM LLC increased its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.